These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 12436935)

  • 1. Molecular pharmacology and modeling of vasopressin receptors.
    Thibonnier M; Coles P; Thibonnier A; Shoham M
    Prog Brain Res; 2002; 139():179-96. PubMed ID: 12436935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The basic and clinical pharmacology of nonpeptide vasopressin receptor antagonists.
    Thibonnier M; Coles P; Thibonnier A; Shoham M
    Annu Rev Pharmacol Toxicol; 2001; 41():175-202. PubMed ID: 11264455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pharmacology of human vasopressin receptors.
    Thibonnier M; Conarty DM; Preston JA; Wilkins PL; Berti-Mattera LN; Mattera R
    Adv Exp Med Biol; 1998; 449():251-76. PubMed ID: 10026814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands.
    Serradeil-Le Gal C; Wagnon J; Valette G; Garcia G; Pascal M; Maffrand JP; Le Fur G
    Prog Brain Res; 2002; 139():197-210. PubMed ID: 12436936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and therapeutic indications of orally-active non-peptide vasopressin receptor antagonists.
    Paranjape SB; Thibonnier M
    Expert Opin Investig Drugs; 2001 May; 10(5):825-34. PubMed ID: 11322860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular aspects of vasopressin receptor function.
    Schöneberg T; Kostenis E; Liu J; Gudermann T; Wess J
    Adv Exp Med Biol; 1998; 449():347-58. PubMed ID: 10026824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor.
    Thibonnier M; Auzan C; Madhun Z; Wilkins P; Berti-Mattera L; Clauser E
    J Biol Chem; 1994 Feb; 269(5):3304-10. PubMed ID: 8106369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of interactions responsible for vasopressin binding to human neurohypophyseal hormone receptors-molecular dynamics study of the activated receptor-vasopressin-G(alpha) systems.
    Slusarz MJ; Giełdoń A; Slusarz R; Ciarkowski J
    J Pept Sci; 2006 Mar; 12(3):180-9. PubMed ID: 16114100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.
    Manning M; Stoev S; Chini B; Durroux T; Mouillac B; Guillon G
    Prog Brain Res; 2008; 170():473-512. PubMed ID: 18655903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist.
    Tahara A; Saito M; Sugimoto T; Tomura Y; Wada K; Kusayama T; Tsukada J; Ishii N; Yatsu T; Uchida W; Tanaka A
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):63-9. PubMed ID: 9459574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and design of novel and selective vasopressin and oxytocin agonists and antagonists: the role of bioassays.
    Chan WY; Wo NC; Stoev ST; Cheng LL; Manning M
    Exp Physiol; 2000 Mar; 85 Spec No():7S-18S. PubMed ID: 10795902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and therapeutic indications of orally-active non-peptide vasopressin receptor antagonists.
    Thibonnier M
    Expert Opin Investig Drugs; 1998 May; 7(5):729-40. PubMed ID: 15991964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modeling of interactions of the non-peptide antagonist YM087 with the human vasopressin V1a, V2 receptors and with oxytocin receptors.
    Giełdoń A; Kaźmierkiewicz R; Slusarz R; Ciarkowski J
    J Comput Aided Mol Des; 2001 Dec; 15(12):1085-104. PubMed ID: 12160092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic interaction of human vasopressin/oxytocin receptor subtypes with G protein-coupled receptor kinases and protein kinase C after agonist stimulation.
    Berrada K; Plesnicher CL; Luo X; Thibonnier M
    J Biol Chem; 2000 Sep; 275(35):27229-37. PubMed ID: 10858434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of neurohypophysial hormone receptor domains involved in ligand binding and G protein coupling.
    Postina R; Kojro E; Fahrenholz F
    Adv Exp Med Biol; 1998; 449():371-85. PubMed ID: 10026828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the binding site of arginine vasopressin to V1a and V1b vasopressin receptors.
    Rodrigo J; Pena A; Murat B; Trueba M; Durroux T; Guillon G; Rognan D
    Mol Endocrinol; 2007 Feb; 21(2):512-23. PubMed ID: 17082326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conserved aromatic residues in the transmembrane region VI of the V1a vasopressin receptor differentiate agonist vs. antagonist ligand binding.
    Cotte N; Balestre MN; Aumelas A; Mahé E; Phalipou S; Morin D; Hibert M; Manning M; Durroux T; Barberis C; Mouillac B
    Eur J Biochem; 2000 Jul; 267(13):4253-63. PubMed ID: 10866830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of the human vasopressin receptor subtypes stably expressed in Chinese hamster ovary cells.
    Tahara A; Saito M; Sugimoto T; Tomura Y; Wada K; Kusayama T; Tsukada J; Ishii N; Yatsu T; Uchida W; Tanaka A
    Br J Pharmacol; 1998 Dec; 125(7):1463-70. PubMed ID: 9884074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene and cDNA cloning and characterization of the mouse V3/V1b pituitary vasopressin receptor.
    Ventura MA; René P; de Keyzer Y; Bertagna X; Clauser E
    J Mol Endocrinol; 1999 Jun; 22(3):251-60. PubMed ID: 10343284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regions.
    Mouillac B; Chini B; Balestre MN; Elands J; Trumpp-Kallmeyer S; Hoflack J; Hibert M; Jard S; Barberis C
    J Biol Chem; 1995 Oct; 270(43):25771-7. PubMed ID: 7592759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.